Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.49 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.49 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.49 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.43 |
| ▸ | CSF1R | P07333 | 1/20 | 0.43 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.43 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.43 |
| ▸ | LTK | P29376 | 1/20 | 0.43 |
| ▸ | KDR | P35968 | 1/20 | 0.43 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.43 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.43 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.43 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.43 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.43 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.43 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.43 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.43 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL196912 | 0.86 | PARP1 (0.42) | ADORA3ADORA2AADORA1ACVR1SMN1; SMN2 | |
| SCHEMBL17231595 | 0.82 | ACVR1 (0.49) | ADORA3ADORA2AADORA1MAP4K4CSF1R | |
| SCHEMBL3860255 | 0.78 | ADORA3 (0.46) | ADORA3ADORA2AADORA1MAP4K4CSF1R | |
| SCHEMBL4978029 | 0.78 | KDM4E (0.45) | ACVR1SMN1; SMN2MAPTNPC1RAB9A | |
| Benzimidazole SCHEMBL28321765 | 0.77 | QPCT (0.50) | ADORA3ADORA2AADORA1SMN1; SMN2MAPT | |
| SCHEMBL21323987 | 0.77 | SMN1; SMN2 (0.44) | CDK5ACVR1SMN1; SMN2MAPTCYP3A4 | |
| SCHEMBL29068393 | 0.76 | PARP1 (0.35) | ADORA3ADORA2AADORA1ACVR1SMN1; SMN2 | |
| SCHEMBL28053350 | 0.75 | PARP1 (0.58) | LIMK1ACVR1CLK4SMN1; SMN2MAPT | |
| SCHEMBL8889421 | 0.75 | ADORA1 (0.51) | ADORA3ADORA2AADORA1SMN1; SMN2MAPT | |
| SCHEMBL7090029 | 0.75 | ADORA2A (0.51) | ADORA3ADORA2AADORA1FGFR1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109566374-B | High-yield pea seedling and planting method thereof | 刘斌 | 2021-04-06 | — | — | CN | claimed |
| CN-109566374-A | A kind of high yield pea seedlings and its implantation methods | 李靖 | 2019-04-05 | — | — | CN | claimed |
| CN-119894230-A | Light emitting element, method for manufacturing light emitting element, and display device | 三星显示有限公司 | 2025-04-25 | — | — | CN | disclosed |
| US-20240174583-A1 | PROCESSES FOR THE VAPOR PHASE HYDROGENATION OF ALDEHYDES | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2024-05-30 | — | — | US | disclosed |
| EP-4347544-A1 | PROCESSES FOR THE VAPOR PHASE HYDROGENATION OF ALDEHYDES | Dow Technology Investments LLC (US) | 2024-04-10 | — | — | EP | disclosed |
| CN-117242047-A | Process for the vapor phase hydrogenation of aldehydes | 陶氏技术投资有限责任公司 | 2023-12-15 | — | — | CN | disclosed |
| US-11708346-B2 | Treatment and prevention of neuropathic pain with P2Y14 antagonists | SAINT LOUIS UNIVERSITY (US) | 2023-07-25 | — | — | US | disclosed |
| CN-115103736-B | Soldering flux and soldering paste | 千住金属工业株式会社 | 2023-07-14 | — | — | CN | disclosed |
| US-11584736-B2 | Heterocyclic P2Y14 receptor antagonists | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-02-21 | — | — | US | disclosed |
| WO-2022250790-A1 | PROCESSES FOR THE VAPOR PHASE HYDROGENATION OF ALDEHYDES | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2022-12-01 | — | — | WO | disclosed |
| CN-109566351-B | Culture medium for improving germination rate | 上海派布利克贸易有限公司 | 2021-10-26 | — | — | CN | disclosed |
| US-20150376101-A1 | HETEREOCYCLIC AGENT AS CATALYTIC STABILIZING AGENT IN A HYDROFORMYLATION PROCESS | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY LLC | 2015-12-31 | — | — | US | disclosed |
| CN-105073701-A | Hetereocyclic agent as catalytic stabilizing agent in a hydroformylation process | DOW TECHNOLOGY INVESTMENTS LLC | 2015-11-18 | — | — | CN | disclosed |
| WO-2014149915-A1 | HETEREOCYCLIC AGENT AS CATALYTIC STABILIZING AGENT IN A HYDROFORMYLATION PROCESS | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2014-09-25 | — | — | WO | disclosed |
| CN-102236259-A | Radiation sensitivity resin composition for display element, interlayer insulation film, protective film and spacer and forming method thereof | JSR CORP | 2011-11-09 | — | — | CN | disclosed |
| EP-1234573-A1 | Anti-inflammatory pharmaceutical compositions and their manufacturing process | Menarini France S.A. (FR) | 2002-08-28 | — | — | EP | disclosed |
| EP-0873292-B1 | IMPROVED METAL-LIGAND COMPLEX CATALYZED PROCESSES | UNION CARBIDE CHEM PLASTIC (US) | 2001-12-19 | — | — | EP | disclosed |
| EP-0873292-A1 | IMPROVED METAL-LIGAND COMPLEX CATALYZED PROCESSES | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1998-10-28 | — | — | EP | disclosed |
| US-5731472-A | HETEROCYCLIC NITROGEN COMPOUNDS | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1998-03-24 | — | — | US | disclosed |
| WO-1997020798-A1 | IMPROVED METAL-LIGAND COMPLEX CATALYZED PROCESSES | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1997-06-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150376101-A1 | HETEREOCYCLIC AGENT AS CATALYTIC STABILIZING AGENT IN A HYDROFORMYLATION PROCESS | NUDT1, CAT, HRAS | ADORA3 3345/4885ADORA2A 1299/4885ADORA1 3187/4885 |
| US-11708346-B2 | Treatment and prevention of neuropathic pain with P2Y14 antagonists | P2RY14, P2RY4, P2RY13 | ADORA3 46/4885ADORA2A 50/4885ADORA1 72/4885 |
| US-11584736-B2 | Heterocyclic P2Y14 receptor antagonists | P2RY14, P2RY1, P2RY13 | ADORA3 43/4885ADORA2A 74/4885ADORA1 33/4885 |
| US-20240174583-A1 | PROCESSES FOR THE VAPOR PHASE HYDROGENATION OF ALDEHYDES | ADH1C, ADH5, ALDH2 | ADORA3 3820/4885ADORA2A 4014/4885ADORA1 4088/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.